Filtyp
Inducing anti-tumor immunity with in-situ direct reprograming of cancer cells to cDC1sNext generation immuno-oncological targets for cancer therapySubtype-dependent biomarkers for systemic therapy in bladder cancer
https://www.createhealth.lth.se/canfaster/ongoing-canfaster-postdoc-projects - 2025-11-19
Immunotherapy has transformed the cancer treatment landscape leading to long-term responses. However, these strategies are effective in a limited number of patients and often lose their efficacy as the tumor progresses. Insufficient antigen presentation mediated by MHC downregulation and exclusion of functional antigen-presenting cells (APCs) from the tumor microenvironment (TME) are critical evas
Immuno-oncological (I-O) treatment methods have revolutionized cancer therapy and tremendous clinical benefits are achieved in some cancer patients. However, today a limited number of I-O drug targets are used and only a fraction of all cancer patients has a therapeutic response. We need to further understand the immune system in cancer in order to develop novel treatment strategies and improve su
Cancer in the urinary bladder afflicts around 3000 persons per year in Sweden, most often older men and smokers. Despite being a quite common cancer type it is an understudied cancer type considering the burden to society and health outcomes [1].To patients with superficial cancer limited to the mucosa of the urinary bladder, the prognosis is good, but once the tumor has grown into the muscle-laye
Address Medicon Village - Building 406Sheelevägen 2 223 81 LundSweden Are you applying for a position? For general questions regarding the call, contact us at:canfaster-postdoc [at] immun [dot] lth [dot] se (canfaster-postdoc[at]immun[dot]lth[dot]se) DirectorSara Ek, Professorsara [dot] ek [at] immun [dot] lth [dot] se (sara[dot]ek[at]immun[dot]lth[dot]se)+46-46-222-3824 Research coordinatorJana H
https://www.createhealth.lth.se/canfaster/contact - 2025-11-19
Please wait... Address Medicon VillageBuilding 406Scheelevägen 2 223 81 LundSweden
https://www.createhealth.lth.se/contact - 2025-11-19
Our approach is translational - It starts from a specific need, identified by our clinical partners. We use novel technological approaches to find the relevant solutions, which can be implemented into the clinic with much shorter lead times. CREATE Health, inaugurated in 2006 with a focus on precision medicine, is a strategic centre for translational research focusing on the early diagnosis and pr
https://www.createhealth.lth.se/about - 2025-11-19
Promising results for Lead Biologics’ first-in-class checkpoint inhibitor published in Nature Cancer Lead Biologics takes a major step towards a new cancer treatment. A new study shows that the company’s drug candidate effectively inhibits a previously unknown immune escape mechanism and eliminates acute myeloid leukemia cells in advanced experimental models.– This confirms the great interest in
https://www.createhealth.lth.se/news-0 - 2025-11-19
Focus AreasPsychological Resilience in Cancer, Bioinformatics and AIOngoing Collaborations and partnersCantargia, IMMUNOVIA, Paindrainer, Akuru PharmaSpin OutsWorking together is an integral part of CREATE Health’s DNA
https://www.createhealth.lth.se/research-and-innovation - 2025-11-19
CREATE Health has been a leader in developing novel therapeutic and diagnostic innovations, which have been further developed in a commercial setting in a start-up company. Immuno-OncologyImmuno-oncology has provided a number of very exciting clinical improvements, by focussing on how the immune system regulates tumor eradication. This has been achieved by the discovery and functional implementati
https://www.createhealth.lth.se/research-and-innovation/focus-areas - 2025-11-19
In 2025, CREATE Health Translational Cancer Center received a donation from the Mrs Berta Kamprad’s Cancer Foundation of 420 million SEK. This is the single largest donation to Lund University, since its founding in 1666. The funds are distributed over a five-year period and dedicated to translational cancer research within the L2CancerBridge program.Other previous and current funding for the CREA
https://www.createhealth.lth.se/about/funding - 2025-11-19
Welcome to the Department of Communications Regardless of whether you are already studying at the Department of Communication or whether you will be doing so in the future, you can look forward to an exciting and stimulating time with committed lecturers and fellow students. On this page you will find links to all the information you need as a student at the Department of Communication. As we are
https://www.iko.lu.se/en/education/study-information - 2025-11-19
Research activities organised by the Department of Communication. Upcoming:26th Annual EUPRERA Congress 2025: At the Intersection between Academia and Practice in Public Relations and Strategic CommunicationA selection of previous activities:The 2nd Symposium of the Nordic Network on Media, Communication & Health (2024) 2023 International Communication Association (ICA) Preconference: Organizing
https://www.iko.lu.se/en/research/conferences-and-workshops - 2025-11-19
The Nordic Network on Media, Communication, and Health (NNMCH) originated from a temporary working group at the NordMedia Conference in Malmö in 2019. Since then, the group has grown from 15 to approximately 40 junior and senior scholars. The group convenes regularly at the biannual NordMedia conference. The network was formally established in Lund, Sweden, during a two-day symposium and meeting f
JournalismVisits: Media Evolution, Stora Varvsgatan 6A, MalmöPost: Box 117, 221 00 LundInvoices: Box 188, 221 00 LundFind us (Google Maps)Media and Communication StudiesVisits: Allhelgona kyrkogata 18c, Gamla PoliklinikenPost: Box 117, 221 00 LundInvoices: Box 118, 221 00 LundFind us (Google Maps)Strategic CommunicationVisits: Campus Helsingborg, Universitetsplatsen 2, HelsingborgPost: Box 882, 25
https://www.iko.lu.se/en/contact/addresses - 2025-11-19
Project HAIDI The project Demography and Democracy – Healthy Ageing in a Digital World (HAIDI) addresses two critical challenges for the Nordic countries and their ageing population: digitalisation and health development. The purpose is to provide new knowledge to counteract health disparities related to the changing demographic patterns and neutralize digital divides threatening inclusion and dem
https://www.iko.lu.se/en/haidi - 2025-11-19
The academic year consists of one fall and one spring semester (60 ECTS for the full academic year). The autumn semester last from the beginning of September to mid-January, but there are no teaching activities during Christmas and the New Year). The spring semester lasts from mid-January to the beginning of June. Semester 1 (fall)The first semester of the Master of Science Program in Strategic Co
At the Intersection between Academia and Practice in Public Relations and Strategic Communication About the EUPRERA Annual Congress The European Public Relations Education and Research Association (EUPRERA) is an autonomous organisation with over 550 members across 50 countries, with a vision of advancing academic research and knowledge in public relations and strategic communication. To achieve t
https://www.iko.lu.se/en/EUPRERA2025 - 2025-11-19
At the Intersection between Academia and Practice in Public Relations and Strategic Communication Register here Download PDF EUPRERA Annual Congress 2025.pdf Submission Requirements Best Paper Awards and Publications Important dates Track One: Strategic Communication and Societal Impact Sustainable development is one of the most significant “wicked” problems we must deal with. In 2015, all members
https://www.iko.lu.se/en/EUPRERA2025/call-papers - 2025-11-19
The EUPRERA Annual Congress accepts conceptual, theoretical, and empirical works and different methodological approaches advancing the public relations and strategic communication discipline and profession. Three types of Submissions are possibleShort-length paper (double-blind review)Full-length research paper (double-blind review)Panel proposalShort-length and full-length research papers are com
https://www.iko.lu.se/en/EUPRERA2025/call-papers/submission-requirements - 2025-11-19
